Dashenlin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 36.7% in First Quarter of 2023

Dashenlin Pharmaceutical Group Co.,Ltd. (大参林医药集团股份有限公司) (603233.SH) reported a net profit of 524.3 million yuan in the first quarter of 2023, up 36.7% year-on-year.

Meanwhile, the company posted 5.9 billion yuan in revenue, up 27.2% year-on-year.

At the end of the reporting period, it had 21.2 billion yuan in total assets and 13.6 billion yuan in total liabilities, with a liability-to-asset ratio of 64.2%.